These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19550293)

  • 1. Smac mimetics as new cancer therapeutics.
    Chen DJ; Huerta S
    Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells.
    Abe S; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Takizawa T; Kitagawa M
    Exp Mol Pathol; 2007 Dec; 83(3):405-12. PubMed ID: 17521628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways].
    Korga A; Korobowicz E; Dudka J
    Pol Merkur Lekarski; 2006 May; 20(119):573-6. PubMed ID: 16875166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity.
    Vogler M; Giagkousiklidis S; Genze F; Gschwend JE; Debatin KM; Fulda S
    Oncogene; 2005 Nov; 24(48):7190-202. PubMed ID: 16091752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Smac/DIABLO in cancer progression.
    Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
    J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac mimetics as IAP antagonists.
    Fulda S
    Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
    Zhu H; Li Y; Liu Y; Han B
    ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
    Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of potent, conformationally constrained Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Liu M; Tomita Y; Pan H; Yoshioka Y; Krajewski K; Roller PP; Wang S
    J Am Chem Soc; 2004 Dec; 126(51):16686-7. PubMed ID: 15612682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
    Górka M; Lamparska-Przybysz M; Motyl T
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL915-22. PubMed ID: 17666167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smac/DIABLO is required for effector caspase activation during apoptosis in human cells.
    Rajalingam K; Oswald M; Gottschalk K; Rudel T
    Apoptosis; 2007 Aug; 12(8):1503-10. PubMed ID: 17440818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
    Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
    J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
    Sun Q; Zheng X; Zhang L; Yu J
    Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promises and Challenges of Smac Mimetics as Cancer Therapeutics.
    Fulda S
    Clin Cancer Res; 2015 Nov; 21(22):5030-6. PubMed ID: 26567362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
    Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.